Initially targeted towards Type 2 diabetes, the significant weight loss benefits observed with GLP-1 RAs such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda ) and tirzepatide (Mounjaro) have led to these treatments becoming blockbuster weight management therapies as well as effective diabetes medications
rose during trading Wednesday following the news
Thomas A, Grgens C, Guddat S, et al
Pregnancy and breastfeeding are periods where these therapies are generally deferred, since they are not studied in those groups, and anyone managing a serious or unstable medical condition should be evaluated and cleared before starting
What if my nausea gets worse with split dosing
TISSUE HEALING & REGENERATION